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Influenza virus ribonucleoproteins (RNPs) were reconstituted in vivo from cloned cDNAs expressing the
three polymerase subunits, the nucleoprotein (NP), and short template RNAs. The structure of purified RNPs
was studied by electron microscopy and image processing. Circular and elliptic structures were obtained in
which the NP and the polymerase complex could be defined. Comparison of the structure of RNPs of various
lengths indicated that each NP monomer interacts with approximately 24 nucleotides. The analysis of the
amplification of RNPs with different lengths showed that those with the highest replication efficiency contained
an even number of NP monomers, suggesting that the NP is incorporated as dimers into newly synthesized
RNPs.
The genome of influenza A virus consists of eight ribonu-
cleoprotein complexes (vRNPs) containing a single-stranded
RNA segment of negative polarity associated to nucleoprotein
(NP) molecules and bound to the polymerase. This enzyme is
a heterotrimer formed by the PB1, PB2, and PA proteins (11,
12, 25, 29), all of them being required for efficient RNA tran-
scription and replication (52) (B. Perales, unpublished data).
Both transcription and replication take place in the nucleus of
the infected cells (24, 27). The replication of viral RNA
(vRNA) involves the generation of a full-length RNA copy of
positive polarity that is encapsidated with NP molecules and
complexed with the polymerase (cRNP). These cRNPs serve as
intermediates for the synthesis of vRNA progeny molecules
(22). For RNA transcription, capped primers generated from
cellular hnRNAs by a cap-stealing mechanism (35) are elon-
gated by copying the vRNA template. The termination and
polyadenylation signal consists of an oligo(U) sequence lo-
cated close to the 59 terminus of the vRNA templates (59, 64)
next to the panhandle structure (38). These processes require
the interaction of the polymerase with the conserved 59-termi-
nal sequences of the template (58, 61, 62).
The polymerase domains involved in intersubunit interac-
tions have been identified (21, 51, 53, 73, 78), as well as the
sequences in PB1 that bind the vRNA template (19, 36) and
the cRNA template (20). The PB1 protein contains amino acid
motifs present in other RNA-dependent RNA polymerases
(56), whose mutation abolishes the transcriptional activity (5).
The PB2 subunit is involved in the initiation of viral transcrip-
tion (3, 51). It is a cap-binding protein (6, 70, 74) and contains
the cap-dependent endonuclease activity (37). The biochemi-
cal role of the PA subunit is still uncertain. The phenotypes of
temperature-sensitive mutants (reviewed in reference 39) sug-
gest its involvement in vRNA synthesis. The PA subunit is a
phosphoprotein (68) whose expression by transfection leads to
the degradation of coexpressed proteins (67, 69).
The structure of the RNPs present in influenza virions has
been studied by electron microscopy (9, 23, 28, 57). They
consist of a ribbon-like cord, held together at its ends and
folded back to form a coiled structure with a terminal loop.
The available evidence indicates that each unit in the ribbon is
a molecule of NP, and the polymerase is present at one end of
the supercoil (46) and helps in keeping the ends linked to-
gether (32). The main component of the RNP is the NP, a basic
protein capable of binding RNA without sequence specificity
(1, 4) in such a way that the sugar-phosphate backbone is
protected from modification (4). Complexes of viral RNA and
NP molecules reconstituted in vitro show structural and bio-
chemical properties similar to those of natural RNPs (31, 76).
Purified NP, which is essentially RNA-free, is also able to
self-assemble to generate oligomers and coiled structures anal-
ogous to RNPs (66).
Up to now, the flexibility and heterogeneity of the RNPs
have prevented electron microscopy from getting medium- to
high-resolution information by averaging techniques, and thus
only their general morphological features are available. In this
report we present an optimized procedure to reconstitute in
vivo viral RNPs from cloned genes that allowed the purifica-
tion of essentially single-size classes of mini-RNPs. The anal-
ysis of such specimens by electron microscopy, combined with
classification and averaging techniques, revealed the presence
of the NP monomers and the polymerase complex. Further-
more, combination of these structural data with the replication
properties of reconstituted mini-RNPs with different sizes sug-
gests that the NP molecules are incorporated as dimers into
progeny RNPs.
MATERIALS AND METHODS
Biological materials. The COS-1 cell line (18) was provided by Y. Gluzman
and was cultivated as described previously (47). The vaccinia recombinant virus
vTF7-3 (16) was a gift of B. Moss. The origin of plasmids pGPB1, pGPB2, pGPA,
and pGNPpolyA has been described previously (44, 52). Plasmid 2.0 (2) was
kindly provided by A. Ball. Plasmid pNS3, containing the NS sequence of influ-
enza A/Victoria/3/75 under the T7 promoter, was provided by A. Portela. An
anti-PB1 protein serum was prepared by immunization of rabbits with purified
PB1 protein obtained by isolation from sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels. The antiserum specific for NP protein (1)
was a gift of A. Portela. The origin of anti-PB2 and anti-PA monoclonal anti-
bodies has been described (3).
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Mutant construction. The plasmids used for in vivo transcription of influenza
virus model vRNAs were constructed as follows. First, the intermediate cloning
vector pUC19RT was generated by inserting the SmaI-XbaI fragment of plasmid
2.0, which contains the cDNA copy of the hepatitis d virus ribozyme and the
T7 RNA polymerase terminator (2), into pUC19. To construct plasmids
pT7NSCAT-RT and pT7NS-RT, PCR fragments were amplified by using as
templates plasmids pIVACAT1/S (54) and pNS3, respectively. The primers used
were 59-AGCAAAAGCAGG-39, which is complementary to the 39 end of the NS
RNA segment, and 59-GCCTGGTACC-TAATACGACTCACTATA-AGTAG
AAACAAGG-39, which contains an Asp718 restriction site, the T7 RNA poly-
merase promoter (underlined) and the 59-terminal sequence of the NS segment.
Finally, the PCR fragments were digested with Asp718 restriction nuclease and
ligated with the SmaI/Asp718-digested pUC19RT. Plasmid pT7NSDCAT-RT
was constructed from pT7NSCAT-RT by deletion of the BsmI restriction frag-
ment internal to the cat gene. To generate a library of deletions of plasmid
pT7NS-RT, the plasmid was digested with nucleases MunI and XcmI, treated
with Bal31 nuclease for various times, and then self-ligated. The NS sequence
from individual plasmid clones was determined, and the plasmids were used for
reconstitution of RNPs as described below.
Transfection. Cultures of COS-1 cells were infected with vTF7-3 virus at a
multiplicity of infection of 5 PFU per cell. After virus adsorption for 1 h at 37°C,
the cultures were washed with Dulbecco modified Eagle medium (DMEM) and
transfected with a mixture of plasmids containing (for 100-mm dishes) pGPB1
(3 mg), pGPB2 (3 mg), pGPA (0.6 mg), pGNPpolyA (12 mg), and either
pT7NSDCAT-RT or pT7DNSRT clones (12 mg). The DNA mixtures were di-
luted to 0.5 ml in DMEM and, in a separate tube, cationic liposomes (2 ml/mg of
DNA) were diluted to 0.5 ml in DMEM. The contents of both tubes were mixed,
kept at room temperature for 15 min, and added to the culture plates containing
4 ml of DMEM. When RNA was transfected instead of a ribozyme construct, the
procedure was as described earlier (52). After 24 h of incubation at 37°C, the
medium was replaced by 10 ml of DMEM containing 2% fetal bovine serum and
incubated for further 24 h. Cationic liposomes were prepared as described
previously (65).
RNP purification. Cultures infected and transfected as indicated above were
collected 48 h after transfection and lysed for 2 h at 0°C in buffer A (10 mM
Tris-HCl–1 mM EDTA–7.5 mM ammonium sulfate–0.025% NP-40–1 mM di-
thiothreitol, pH 7.9). After centrifugation at 10,000 3 g for 30 s at 4°C, the
extract was centrifuged on a 20 to 35% glycerol gradient in TN buffer (150 mM
NaCl–50 mM Tris-HCl, pH 7.8) for 17 h at 35,000 rpm and 4°C in an SW41 rotor.
Fractions containing active RNPs were pooled and centrifuged in a step glycerol
gradient in TN buffer (48) for 8 h at 55,000 rpm and 4°C in an SW55 rotor. Active
fractions were pooled and used for further analyses.
RNA analyses. The synthesis of vNSZ and cNSZ probes was carried out as
described earlier (52). They were used for dot hybridization as described previ-
ously (43). In vitro RNA synthesis reactions were performed as indicated previ-
ously (51). To identify the active RNP fractions in the glycerol gradients, aliquots
of each one were used for in vitro RNA synthesis, the products were precipitated
with 10% trichloroacetic acid (TCA) and filtered in a dot blot apparatus, and the
membrane was autoradiographed. To assay the relative amplification of deletion
library clones, extracts of infected and transfected cells were used for in vitro
RNA synthesis, and the purified RNA products were separated by denaturing
polyacrylamide-urea gel electrophoresis (51). The RNA bands were quantitated
in a phosphorimager, and the data were corrected by use of the relative RNA
lengths of the clones. When indicated, the synthesized RNA was separated by
chromatography in oligo(dT) cellulose as described earlier (51).
Protein analyses. Western blotting was carried out as described elsewhere
(43). In brief, cell extracts were separated by SDS-PAGE and transferred to
Immobilon filters, and the membranes were saturated with 3% bovine serum
albumin for 1 h at room temperature. The filters were incubated with either
anti-PB1 serum (1:500 dilution), anti-NP serum (1:300 dilution), or anti-PA
monoclonal antibodies or anti-PB2 monoclonal antibodies (1:40 dilution of cul-
ture supernatants) for 1 h at room temperature. The filters were washed two
times for 30 min with phosphate-buffered saline containing 0.25% Tween 20 and
were incubated with a 1:10,000 dilution of goat anti-rabbit immunoglobulin G
(IgG) or goat anti-mouse IgG conjugated to horseradish peroxidase. Finally, the
filters were washed two times for 30 min as above and developed by enhanced
chemiluminescence.
Electron microscopy and image processing. Samples were adhered to carbon-
coated collodion grids previously glow discharged in low air pressure. In some
experiments, the RNPs were previously hybridized with a positive-polarity oli-
gonucleotide specific for the vRNA template (hybridization for 10 min with a
100-fold excess of oligonucleotide in 150 mM NaCl–50 mM Tris-HCl [pH 7.5])
in order to increase the adhesion to the grids. Staining was performed with 2%
uranyl acetate. For visualization of RNP-antibody complexes, RNPs adsorbed
onto grids were washed twice with 150 mM NaCl–50 mM Tris-HCl (pH 7.5) and
incubated for 1 h at 37°C with a 1:1,000 dilution of monoclonal antibody PB2-25
(3). After a washing with the same buffer, the sample was stained as indicated
above. Transmission electron micrographs were recorded by using a low-dosage
protocol at an approximate magnification of 360,000 in a JEOL 1200 EXII
microscope. Micrographs were digitized at 4 Å/pixel by using an Eikonix 1412
digital camera. Images corresponding to RNPs (130 by 130 pixels) were ex-
tracted, centered, and aligned by using a free-pattern algorithm (42, 49). Due to
the heterogeneity of the images, the aligned projections of the RNPs were
subjected to self-organizing Kohonen maps (33, 41). After this classification,
homogeneous populations were obtained and averaged. The resolution of the
average images was estimated by the spectral signal-to-noise ratio method (75).
Final average images were filtered to the resolution obtained in each case, as
indicated in the figure legends.
RESULTS
Purification of biologically active viral RNPs reconstituted
from cloned genes. Several experimental approaches have
been used to reconstitute in vivo active influenza virus RNPs
from cloned genes. The expression of the polymerase subunits
and the NP has been obtained by infection with recombinant
vaccinia viruses (26), by infection with simian virus 40 recom-
binant viruses (10), by use of polymerase II-driven constructs
(30, 55), and by transfection into vaccinia T7 virus-infected
cells (44; reviewed in reference 45). Usually, an in vitro tran-
script modeled on a vRNA segment has been provided by
direct RNA transfection (10, 26), by a construct driven by
polymerase I (15), and terminated by a ribozyme sequence
(55). These approaches have allowed the determination of the
viral components essential for activity and the characterization
of mutants affected in the polymerase subunits and the NP
(reviewed in reference 60). However, none of these experi-
mental systems has permitted researchers to purify and analyze
biochemically the reconstituted RNPs. To improve the pre-
vious methods, we transfected a plasmid construct capable
of generating the vRNA model transcript intracellularly
(pT7NSDCAT-RT), instead of a synthetic viral model RNA.
Plasmid pT7NSDCAT-RT contains a 313-nucleotide (nt)
model viral cDNA driven by the T7 promoter and followed by
a hepatitis d virus ribozyme and a T7 terminator. This change,
as well as the optimization of the experimental conditions
indicated in Materials and Methods, led to a significant in-
crease in the yield of active RNPs. A comparison of the results
obtained with previous conditions, in which a 240-nt vRNA
was directly transfected, and present conditions is shown in
Fig. 1 and indicates that the increase in active RNPs obtained
was at least 20-fold. It is clear that no transcription activity in
vitro was obtained when the vRNA template or the ribozyme
construct were omitted (Fig. 1, 2RT). As expected, the recon-
stitution of active RNPs was strictly dependent on the expres-
sion of the NP and each polymerase subunit (Fig. 1).
In view of the efficient RNP reconstitution obtained, we
attempted their biochemical purification according to estab-
lished procedures, i.e., successive centrifugation on velocity
and density glycerol gradients (see Materials and Methods).
The analyses of the last step in the purification are presented
in Fig. 2. The Western blot signals obtained with anti-PB1
serum (Fig. 2A), anti-PB2 and anti-PA (not shown), and an-
ti-NP (Fig. 2B) were all localized to fractions 9 to 13 in the
density gradient. These fractions were shown to contain essen-
tially NP and polymerase subunits when analyzed by Coomas-
sie blue staining (Fig. 2C). Moreover, the in vitro transcription
activity of these fractions strictly correlated with the presence
of NP and polymerase (Fig. 2D, COMP). No in vitro transcrip-
tion activity was detectable in the corresponding fractions of
the gradient obtained from a parallel purification of RNPs
reconstituted in the absence of the ribozyme construct (Fig.
2D, 2RT). Correspondingly, neither NP nor polymerase pro-
tein was detectable by Western blotting in these fractions (data
not shown). In summary, purified preparations of reconstituted
RNPs were obtained by use of the methodology described.
To characterize the purified RNPs, their RNA was extracted
and analyzed by dot blot hybridization with positive- or nega-
tive-polarity riboprobes. As indicated in Fig. 3A, the reconsti-
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tuted RNPs contained mostly vRNA; i.e., they were vRNPs,
with a minor proportion of cRNA. To ascertain whether the
purified RNPs represent active complexes, their in vitro prod-
ucts were characterized by oligo(dT) chromatography and gel
electrophoresis in parallel to those produced by the cell ex-
tracts. The results are presented in Fig. 3B. Like the cell ex-
tract, the purified vRNPs synthesized mRNA (Fig. 3B, RNPs,
A1), as well as a nonpolyadenylated full-length product (Fig.
3B, arrows) and nonpolyadenylated mRNA (Fig. 3B, stars)
(50, 51).
Morphology of reconstituted RNPs. The availability of pu-
rified, transcriptionally active vRNPs reconstituted with a short
model RNA (313 nt) allowed their structural characterization
by electron microscopy. Preparations of vRNPs were visualized
after negative staining, and the images of individual particles
were classified and averaged as described in Materials and
Methods. Two size classes were distinguished: a predominant
one containing 11 repetitive units and a minor one containing
10 units and representing about 30% of the population. A
second classification was performed with the 11-mer size class,
and two conformations were identified: circular and elliptic. A
gallery of individual images of the circular 11-mer size class is
shown in Fig. 4A. The average image of the population with a
circular conformation shows a circular shape, with a single
peak of rotational symmetry at value 11 (32% of the popula-
tion; 296 images) (Fig. 4B and C) and contain 11 morpholog-
ical units that could correspond to NP molecules, with average
sizes of 56 and 76 Å (external base height). Moreover, a con-
spicuous mass was localized to the external side of the circle, a
finding consistent with the presence of the polymerase complex
(see below). The average image of the population with ellip-
soidal conformations (68% of the population; 641 images; Fig.
4E) confirmed the presence of 11 NP units but failed to show
the polymerase. This result could be due to a stronger weight
of the ellipticity over the polymerase boundary in the aligning
procedure, leading to the positive enhancement of the NP
units in the ring and discarding the polymerase image. Only if
the polymerase had been placed in a fixed position with respect
to the ellipse axis would a positive averaging have taken place.
Since this was not the case, the polymerase image was averaged
out.
The identification of the outer morphological units as the
polymerase complex was carried out by electron microscopy of
vRNPs complexed with anti-PB2 monoclonal antibodies. As
shown in Fig. 4F, images consistent with antibody molecules
labeling the presumptive polymerase complex could be de-
tected in individual vRNPs (arrowheads). Furthermore, poly-
merase complexes of two vRNPs were sometimes found linked
by interaction to an individual antibody molecule (Fig. 4G,
arrowheads). The variability of the images obtained for the
RNPs suggested some degree of flexibility in the relative po-
sitions of the NP and the polymerase. To generate an improved
image of the latter, the area of each image containing the
polymerase (Fig. 4B, circle) was independently processed by
alignment centered on the polymerase complex. In this way, an
enhanced image was obtained, and three domains could be
distinguished within the polymerase complex (Fig. 4D).
The replication efficiency of reconstituted RNPs is length
dependent. To test the possibility that the vRNA length would
impose restrictions on the amplification of the vRNP, in line
with well-known cases of paramyxoviruses (7; reviewed in ref-
erence 34), we took advantage of the strict correlation between
vRNP amplification in vivo and the in vitro activity of the
corresponding cell extracts (data not shown). The experimen-
FIG. 1. Reconstitution of influenza virus mini-RNPs. Cultures of COS-1 cells
were infected with vaccinia T7 virus and transfected with pGPB1, pGPB2, pGPA,
and pGNPpolyA plasmids. The viral template was provided by simultaneous
transfection of pT7NSDCAT-RT plasmid or by delayed transfection of vNSZ
RNA, as indicated in Materials and Methods. After incubation for 48 h, the viral
RNPs were extracted and used for in vitro RNA synthesis by using ApG as
primer. The RNA product was isolated and analyzed by electrophoresis on
sequencing gels. The product obtained after transfection of pT7NSDCAT-RT
(313 nt) is shown (COMP), as well as the product generated by transfection of
vNSZ RNA (240 nt) and those obtained when each of the elements of the
systems was omitted. The panel to the left shows a 203 overexposure of the lane
containing the vNSZ RNA product. The lengths of molecular weight markers are
indicated to the left in nucleotides.
FIG. 2. Purification of influenza virus mini-RNPs reconstituted in vivo. The
viral RNPs reconstituted in vivo as indicated in Fig. 1 were purified by two
successive glycerol gradients as indicated in Materials and Methods. The analyses
corresponding to the fractionation of the second gradient are presented. Ali-
quots of each fraction were processed for Western blotting by using anti-PB1 (A)
or anti-NP antibodies (B) or were analyzed by SDS-PAGE and Coomassie blue
staining (C). The activity of each fraction was determined by in vitro transcrip-
tion and TCA precipitation, filtration on a dot blot apparatus, and autoradiog-
raphy (D, COMP). As a control, the activity of a parallel gradient with a sample
in which no template was transfected (2RT) was determined. Pol and NP
indicate the positions of the polymerase proteins and the NP in the gel, respec-
tively.
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tal approach taken involved the generation of a library of
deleted constructs from plasmid pT7NS-RT by restriction at
internal sites of the NS gene and Bal31 treatment. The clones
obtained were sequenced and used to reconstitute vRNPs, and
the activity in vitro of the corresponding cell extracts was tested
as indicated in Materials and Methods. A diagram of the struc-
ture of the clones and their relative transcriptional activities is
presented in Fig. 5. No specific sequence of the NS gene could
be correlated to a high biological activity of the reconstituted
vRNPs. Clones that had lost portions of the conserved segment
termini were not active (Fig. 5, clone 57). Likewise, deletion of
sequences close to the termini affected the activity of the re-
constituted vRNP (Fig. 5, clone 66), in agreement with previ-
ous results (77). When the relative activity of the various de-
leted clones was represented as a function of their length, the
graph presented in Fig. 6 was obtained. A clear dependence of
the length is apparent, and the pitch of the sinusoidal graph
had an average value of 48 nt. Since the length of viral RNA
complexed to each NP molecule was estimated to be on the
order of 20 nt (8), these results suggest that the entry of the NP
in the replicating RNP occurs as a dimer. Clone 66, containing
a deletion of sequences proximal to the segment terminus, had
an activity lower than expected for its length (Fig. 6, shaded
square), confirming that it lacks sequences required for opti-
mal RNP amplification.
Viral RNPs with highest efficiency of replication contain an
even number of NP molecules. It is worth mentioning that
clone pT7NSDCAT-RT, whose structure has been analyzed
above, corresponds to a minimum in the sinusoidal graph and
predominantly contains 11 NP molecules. These facts suggest
FIG. 3. Characterization of influenza virus RNPs reconstituted in vivo. In-
fluenza virus RNPs were reconstituted and purified as indicated in Fig. 1 and 2.
(A) The RNA contained in the purified RNPs was isolated and analyzed by dot
blot hybridization by using positive (vRNA)- and negative (cRNA)-polarity ri-
boprobes. (B) Either cellular extracts from infected and transfected cells (EX-
TRACT) or purified RNPs (RNPs) were used for in vitro transcription by using
ApG as primer. The in vitro product was purified, fractionated on oligo(dT)
cellulose into poly(A)2 (A2) and poly(A)1 (A1) RNA, and analyzed on a
sequencing gel. The products obtained when the complete reconstitution sys-
tem was used are shown (COMP), as well as a control in which plasmid
pT7NSDCAT-RT was omitted (2RT). The arrowheads indicate the band cor-
responding to a full-length product. The stars show mRNA products deficient in
polyadenylation. Numbers to the left refer to the mobility of molecular weight
markers (in nucleotides).
FIG. 4. Structure of influenza virus NSDCAT RNP. Purified NSDCAT RNPs
were analyzed by electron microscopy after negative staining. The photographic
plates were digitized, and 1,282 images from individual particles were stored and
classified. Each homogeneous class was processed as described in Materials and
Methods. (A) Gallery of circular RNPs. (B) Average image of the population of
circular RNPs (average of 156 images; resolution, 30 Å). (C) Percentage of the
total rotational power of the images presented in panel B plotted for the first 15
harmonics. (D) Average image with an alignment procedure that was centered
on the polymerase complex (average of 55 images; resolution, 35 Å). (E) Aver-
age image of the population of ellipsoid RNPs (average of 871 images). (F)
Gallery of images from RNP–anti-PB2 complexes. (G) Gallery of images from
RNP–anti-PB2 complex dimers. Bar, 15 nm.
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that vRNPs with optimal capacity to amplify in vivo would have
a length sufficient to hold an even number of NP molecules. To
test this prediction, the vRNPs reconstituted with clone 49 (350
nt) were analyzed by electron microscopy and image process-
ing as indicated above for NSDCAT RNPs. The classification
of the images obtained revealed that 80% of the particles
contained 12 NP molecules and minor populations of 11-mers
and 10-mers (10% each). A fraction of the 12-mers (28% of the
population) were circular structures with a single peak of ro-
tational symmetry at value 12 (Fig. 7A). In addition to the NP
monomers, the presence of the polymerase complex was ap-
parent. As with the vRNPs derived from pT7NSDCAT-RT
plasmid, clone 49 vRNPs also contained ellipsoid particles with
12 NP monomers (77% of the population) (Fig. 7C), in which
the polymerase image was averaged out due to the reasons
given above.
DISCUSSION
Improved reconstitution efficiency allows biochemical and
structural analyses of recombinant influenza virus RNPs. The
reconstitution of influenza virus RNPs requires the expression
of the three subunits of the polymerase and the NP, in addition
FIG. 5. Relative amplification efficiency of influenza virus vRNPs reconsti-
tuted from templates of various lengths. Diagram of the structure of the NS
segment (NS) and the collection of deletion derivatives, indicating the sequences
deleted, the transcript length (in parentheses), and the relative activity in the in
vitro transcription assay (taking clone 105 as a reference). The black regions at
the ends represent the sequences conserved among all influenza virus RNA
segments.
FIG. 6. Length dependence of the efficiency of amplification of influenza
virus RNPs. Graphic representation of the data presented in Fig. 5. The curve
was adjusted to a polynomic function by using the program MATLAB 2.0.
FIG. 7. Structure of clone 49 RNP. Purified clone 49 RNPs were analyzed by
electron microscopy after negative staining. The photographic plates were digi-
tized, and 386 images from individual particles were stored and classified. Each
homogeneous class was processed as described in Materials and Methods. (A)
Average image of the population of circular RNPs (average of 44 images; res-
olution, 35 Å). (B) Percentage of the total rotational power of the images
presented in panel A plotted for the first 15 harmonics. (C) Average image of the
population of ellipsoid RNPs (average of 336 images). Bar, 15 nm.
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to the viral RNA template (26). Several experimental ap-
proaches have led to the generation of active RNPs (reviewed
in reference 45), with transfection into vaccinia virus T7-in-
fected cells being the most efficient and effective of these ap-
proaches (44). In this study we have improved this reconstitu-
tion system and the extraction of the RNPs. Thus, instead of
transfecting a model vRNA into cells already expressing the
viral core proteins (44, 51), we cotransfected the viral cDNAs
together with a ribozyme construct capable of intracellularly
generating the viral model template. As indicated in Fig. 1, an
approximately 20-fold-higher yield of active, soluble RNPs was
obtained. Such a result opened the way to the biochemical
purification of the reconstituted RNPs (Fig. 2). It is interesting
that the generation of recombinant RNPs was strictly depen-
dent on the activity of the polymerase, since transfection of a
deletion mutant of PB2 protein, which is inactive in viral tran-
scription and replication but still capable of entering into the
polymerase complex (51), did not allow the generation of bio-
chemically detectable RNPs (data not shown). This result im-
plies that the simple reconstitution of the RNPs from the
T7-directed transcript is not sufficient to account for the accu-
mulation of active RNPs. Rather, amplification mediated by
the viral replication machinery is required. This conclusion,
together with the fact that most of the RNPs generated in vivo
are vRNPs, i.e., contain vRNA (Fig. 3), indicates that a situa-
tion similar to the virus infection is reproduced in the trans-
fected cells: a small amount of the T7-directed transcript (pa-
ternal vRNA) forms active vRNPs that lead to the generation
of a small amount of cRNPs (replication intermediate). These
cRNPs are used as templates for the efficient accumulation of
progeny vRNPs. Thus, the reconstituted RNPs only differ from
authentic ones in their length.
The average image of a reconstituted RNP reveals its struc-
tural elements, the polymerase and the nucleoprotein. The
structure of cellular ribonucleoprotein particles has been ana-
lyzed by electron microscopy and image processing with great
success. By using these techniques, the ribosome has been
studied as a single-particle, noncrystalline sample, and progres-
sively improved data has led to three-dimensional reconstruc-
tions with a resolution of 15 to 25 Å (13, 40). Likewise, the
structures of spliceosomal A complex and the large nuclear
RNP particle have been determined, although to a lower res-
olution (17, 71). However, very few studies of this type have
been carried out with RNPs from negative-strand RNA viruses
(14), and none have been carried out with influenza virus
RNPs. The main reason for this lack of data might be the
flexible nature of viral RNPs, which preclude the application of
image-processing tools. In addition, the influenza virus RNPs
are heterogeneous in size, a fact that may contribute to the
complexity of the problem. The reconstitution of mini-RNPs
from cloned DNA and their purification, albeit to a low con-
centration (Fig. 1 and 2), has allowed the use of essentially
single size class specimens with sufficient rigidity to apply im-
age-processing techniques. The analysis of such images and
their classification showed the presence of a proportion of
circular structures made up of 11 identical elements that
should correspond to NP monomers and an external morpho-
logical unit representing the polymerase complex (Fig. 4). A
31% fraction of the population had only 10 NP monomers, in
addition to the polymerase (data not shown). Interestingly, the
polymerase complex could be directly detected by electron
microscopy for the first time, albeit so far at low resolution, and
the image obtained is consistent with the presence of the three
subunits (Fig. 4). Particle-to-particle differences in staining
and/or the flexibility of the polymerase bound to the panhandle
in relation to the ring of NP monomers might be the reason for
the low resolution obtained and the small apparent mass of the
polymerase complex. Progress in this regard is envisaged in the
use of even smaller reconstituted RNPs.
Two additional features of the collection of images obtained
provide information in regard to the generation of the normal,
coiled structures seen in virion RNPs (28). First, a large frac-
tion of the structures were not strict circles but ellipsoids (Fig.
4 and 7). These elliptic structures might represent initial stages
of the helicity. Second, in this context it is worth mentioning
that the proportion of the elliptic structures was larger for
the RNP reconstituted from clone 49 (350 nt) than from
pT7NSDCAT-RT plasmid (313 nt) and, furthermore, only he-
lical structures could be detected for clone 41-derived RNPs
(400 nt) (data not shown).
The replication efficiency of reconstituted RNPs fluctuates
with their length, with a pitch of 48 nt. The stoichiometry of
NP versus RNA could be calculated from the structure of the
RNP derived from pT7NSDCAT-RT plasmid. Thus, if we as-
sume that the polymerase covers about 12 to 15 nt from each
RNA end as it interacts with the panhandle structure (32, 72),
26 to 28 nt of RNA should be interacting with each NP mono-
mer, in good agreement with previous estimates obtained by
chemical analyses (8). However, a large fraction of the RNPs
generated contained 10 NP monomers instead of 11, a result
that suggested that this RNP might not have the optimal length
for amplification. Keeping in mind the strict requirement for
precise length that some paramyxoviruses show (the rule of six)
(7, 34), we tested whether recombinant templates with differ-
ent lengths might show a similar length dependence, a presum-
able “rule of 26 to 28.” A strict restriction of amplification was
not expected, since influenza virus polymerase interacts di-
rectly with the ends of the RNA template (19, 36, 72) and
should be expected to provide a source of flexibility to the
structure. Indeed, a fluctuation of the amplification efficiency
of the RNPs was observed as a function of their template’s
length but, surprisingly, a pitch of 48 nt was detected (Fig. 6).
The low relative amplification capacity of the RNP derived
from pT7NSDCAT-RT plasmid and the presence of a large
proportion of 10-mers suggested that an even number of NP
monomers should be present in an RNP to allow for its optimal
amplification. Such an assumption was confirmed by the pres-
ence of 12 NP monomers in clone 49 RNPs, which are highly
efficient in amplification (Fig. 6 and 7). The lengths of the
complete viral RNA segments are not always multiples of 48,
probably because the longer RNAs permit enough flexibility to
the structure. However, the increments in length among the
various RNA segments are frequently approximate multiples
of 48. Similarly, the lengths of defective-interfering RNAs iso-
lated from infected cells are frequently, but not always, ap-
proximate multiples of 48 (28). For defective-interfering
RNAs, however, other restrictions might also operate, such as
the relative positions of appropriate sequences for the jumping
of the polymerase within the RNP (28).
The molecular basis of the fluctuation of the amplification
efficiency with a pitch of 48 is unknown at present. It is tempt-
ing to speculate that the NP molecules are incorporated into
replicating progeny RNAs as dimers. If this were the case, the
terminal dimer entering at the 39 end of the RNA molecule
would be restricted when the length of the RNA deviated from
a multiple of 48, forcing the entry of a monomeric NP mole-
cule instead of a dimer or skipping the incorporation of the last
dimer. In our experiments, the RNP derived from
pT7NSDCAT-RT plasmid incorporates 11 NP monomers but
frequently is terminated at the stage of 10 monomers (i.e., 5
dimers). In line with this speculation, dimeric forms of NP have
been detected in influenza virus-infected cells (63). However,
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no evidence for dimers of NP was found by electron micros-
copy of purified protein (66).
In summary, application of image-processing techniques to
electron microscopy images of in vivo-reconstituted influenza
virus RNPs has provided the first images of the viral polymer-
ase complex and helped to obtain a more precise picture of the
NP monomer. Moreover, the amplification characteristics of
mini-RNPs of various lengths suggested that the NP molecule
is incorporated in progeny RNPs in the form of dimers and
indicated that each NP monomer covers around 24 nt of the
template RNA.
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